Morningstar

AptarGroup Inc ATR

Morningstar Rating
Unlock
Stock XNYS Rating as of
$119.15 +1.43 (1.21%)
View Full Chart
As of Delayed Price Open

Company Report

View Archive

Despite Emergency Medicines Destocking, Aptar's Underlying Business Remains Healthy

Jay Lee

Aptar is a global leader in dispensing technologies and operates under three business segments, Aptar Pharma, Aptar Beauty, and Aptar Closures. The company specializes in various drug dispensing solutions including nasal spray inhalers and elastomer components for injectable drugs, high-end fragrance pumps, and food dispensing closures. While Aptar’s portfolio includes lower-margin products such as shampoo and soap pumps and caps for sauce bottles, it has intentionally focused on growing the higher-margin healthcare business over the past decade, which now accounts for about two thirds of operating profits.

Read Full Report

Price vs Fair Value

View History
ATR is trading at a 468% premium.
Price
$117.72
Fair Value
$272.00
Uncertainty
Lqhjyt
1-Star Price
$294.60
5-Star Price
$261.40
Economic Moat
Dqpffrg
Capital Allocation
Glpwqnv

Bulls Say, Bears Say

Bulls

Aptar’s strong relationships with multinational customers will help the firm expand into emerging markets such as Asia and Latin America.

Bears

Aptar’s negotiating power could decline along with further consolidation of large consumer and pharmaceutical companies.

Show More

News

View All

Trading Information

Previous Close Price
$117.72
Day Range
$118.15–120.74
52-Week Range
$103.23–164.28
Bid/Ask
$118.96 / $119.18
Shares Outstanding
63.82M
Market Cap
$7.60B
Volume/Avg
116,112 / 513,621

Key Statistics

Price/Earnings (Normalized)
20.38
Price/Sales
1.99
Dividend Yield (Trailing)
1.63%
Dividend Yield (Forward)
1.63%
Total Yield
6.73%

Company Profile

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
14,000
Website
https://www.aptar.com

Competitors

Valuation

View More
Metric
ATR
PODD
WST
Price/Earnings (Normalized)
 20.3827.7341.52
Price/Book Value
 2.837.947.85
Price/Sales
 1.993.657.45
Price/Cash Flow
 11.0417.3532.51
Price/Earnings
ATR
PODD
WST

Financial Strength

Metric
ATR
PODD
WST
Quick Ratio
 1.001.491.79
Current Ratio
 1.662.492.71
Interest Coverage
 9.006.79327.00
Quick Ratio
ATR
PODD
WST

Profitability

Metric
ATR
PODD
WST
Return on Assets (Normalized)
 8.62%11.75%14.41%
Return on Equity (Normalized)
 16.10%27.21%19.49%
Return on Invested Capital (Normalized)
 11.72%15.65%17.26%
Return on Assets
ATR
PODD
WST

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
NqbzvfjgvBsfv$146B
 Becton Dickinson & Co
BDX
QkxTzkqm$40B
 Alcon Inc
ALC
HdxtnddxGnpwzd$33B
 Medline Inc Ordinary Shares - Class A
MDLN
LhgcxksdsJfnkydt$31B
 ResMed Inc
RMD
RmwqwhgbdpQyqsgd$28B
 West Pharmaceutical Services Inc
WST
DqswkbbpVgdl$23B
 Solventum Corp
SOLV
YwjcrrtmbYhfj$14B
 The Cooper Companies Inc
COO
GxlzkfqQkwpym$13B
 Align Technology Inc
ALGN
KcgjktfsbYygkwt$13B
 Baxter International Inc
BAX
FmwXfvmcm$11B

Sponsor Center